| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &Chief Financial Officer | SVP &Chief Financial Officer
1 company
Yi Kathy is an EVP &Chief Financial Officer at SANGAMO THERAPEUTICS, INC. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $6K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 16, 2018 | SGMO Sangamo Therapeutics, Inc | SVP &Chief Financial Officer | Sale+OE | 5,000 | $14.77 | $73,860.00 | -40.8% | |
| Jun 15, 2018 | SGMO Sangamo Therapeutics, Inc | SVP &Chief Financial Officer | Sale+OE | 5,000 | $15.67 | $78,365.00 | -40.8% | |
| May 15, 2018 | SGMO Sangamo Therapeutics, Inc | SVP &Chief Financial Officer | Sale+OE | 5,000 | $15.38 | $76,920.00 | -40.8% | |
| Apr 16, 2018 | SGMO Sangamo Therapeutics, Inc | SVP &Chief Financial Officer | Sale+OE | 5,000 | $19.83 | $99,144.00 | -40.8% | |
| Mar 15, 2018 | SGMO Sangamo Therapeutics, Inc | SVP &Chief Financial Officer | Sale+OE | 5,000 | $25.56 | $127,812.00 | -40.8% |